4.7 Article

Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging

Journal

BIOCONJUGATE CHEMISTRY
Volume 28, Issue 8, Pages 2069-2076

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.7b00233

Keywords

-

Funding

  1. AMED-CREST, JST, PRESTO [JPMJPR14F8]
  2. MEXT/JSPS KAKENHI grant [JP16H02606, JP26111012, JP15H05951]
  3. JSPS Core-to-Core Program, Advanced Research Networks
  4. Hoansha Foundation
  5. Uehara Memorial Foundation
  6. Japan Foundation for Applied Enzymology
  7. Grants-in-Aid for Scientific Research [26111012, 15H05951, 16H02606] Funding Source: KAKEN

Ask authors/readers for more resources

Technology to visualize small prostate cancers is urgently needed because of the difficulty of discriminating prostate cancer from normal tissue with the naked eye, and a fluorescence imaging method would be advantageous. Here, we describe the design and synthesis of a fluorogenic probe (Ac-KQLR-HMRG) that is activated by hepsin and matriptase (proteases over-expressed in prostate cancer). Ac-KQLR-HMRG exhibited significant turn-on fluorogenicity in the presence of hepsin (180-fold) and matriptase (80-fold) and allowed specific fluorescence imaging of various prostate cancer cell line in vitro. In addition, the probe enabled rapid imaging (within 1-10 min) of small prostate cancer nodules in mouse models of disseminated peritoneal tumor and orthotopic tumor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available